Word

Status

Dead

Status Code

602

Status Date

Friday, April 19, 2019

Serial Number

88020290

Mark Type

2000

Filing Date

Friday, June 29, 2018

Abandoned Date

Friday, April 5, 2019

Trademark Owner History

Ultragenyx Pharmaceutical Inc.

Classifications

1 Chemical and biochemical products for use in gene delivery technology, namely, nucleic acids, including coding and non-coding deoxyribonucleic acids, ribonucleic acids, plasmids, vectors, promotors, enhancers and other regulatory sequences, all for in-vivo laboratory use in gene therapy

5 Pharmaceutical preparations for the treatment of genetic diseases and disorders; Pharmaceutical preparations for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, hematologic, and fungal and viral diseases and disorders; pharmaceutical preparations for the treatment of cancer, pain, diabetes, damaged skin, damaged tissue and addiction; Gene therapy and prophylaxis products, namely, gene transfer, regulation, modulation and delivery pharmaceutical preparations for the treatment of genetic diseases and disorders

Color is not claimed as a feature of the mark.
The mark consists of DNA-like strand within a hexagon.

Trademark Events

Apr 19, 2019

Abandonment Notice E-Mailed - Failure To Respond

Apr 19, 2019

Abandonment - Failure To Respond Or Late Response

Oct 4, 2018

Notification Of Non-Final Action E-Mailed

Oct 4, 2018

Non-Final Action E-Mailed

Oct 4, 2018

Non-Final Action Written

Oct 1, 2018

Assigned To Examiner

Jul 6, 2018

Notice Of Design Search Code E-Mailed

Jul 5, 2018

New Application Office Supplied Data Entered In Tram

Jul 3, 2018

New Application Entered In Tram